Plasma for prevention and treatment of glycocalyx degradation in trauma and sepsis.
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
20 Jul 2024
20 Jul 2024
Historique:
received:
03
03
2024
accepted:
06
07
2024
medline:
21
7
2024
pubmed:
21
7
2024
entrez:
20
7
2024
Statut:
epublish
Résumé
The endothelial glycocalyx, a gel-like layer that lines the luminal surface of blood vessels, is composed of proteoglycans, glycoproteins, and glycosaminoglycans. The endothelial glycocalyx plays an essential role in vascular homeostasis, and its degradation in trauma and sepsis can lead to microvascular dysfunction and organ injury. While there are no proven therapies for preventing or treating endothelial glycocalyx degradation, some initial literature suggests that plasma may have a therapeutic role in trauma and sepsis patients. Overall, the literature suggesting the use of plasma as a therapy for endothelial glycocalyx degradation is non-clinical basic science or exploratory. Plasma is an established therapy in the resuscitation of patients with hemorrhage for restoration of coagulation factors. However, plasma also contains other bioactive components, including sphingosine-1 phosphate, antithrombin, and adiponectin, which may protect and restore the endothelial glycocalyx, thereby helping to maintain or restore vascular homeostasis. This narrative review begins by describing the endothelial glycocalyx in health and disease: we discuss the overlapping disease mechanisms in trauma and sepsis that lead to its damage and introduce plasma transfusion as a potential therapy for prevention and treatment of endothelial glycocalyx degradation. Second, we review the literature on plasma as an exploratory therapy for endothelial glycocalyx degradation in trauma and sepsis. Third, we discuss the safety of plasma transfusion by reviewing the adverse events associated with plasma and other blood product transfusions, and we examine modern transfusion precautions that have enhanced the safety of plasma transfusion. We conclude that the literature proposes that plasma may have the potential to prevent and treat endothelial glycocalyx degradation in trauma and sepsis, indicating the need for further research.
Identifiants
pubmed: 39033135
doi: 10.1186/s13054-024-05026-7
pii: 10.1186/s13054-024-05026-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
254Subventions
Organisme : National Heart, Lung, and Blood Institute of the National Institutes of Health
ID : T32HL155020
Informations de copyright
© 2024. The Author(s).
Références
World Health Organization. Injuries and violence. Accessed December 9, 2023. https://www.who.int/news-room/fact-sheets/detail/injuries-and-violence
Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–72. https://doi.org/10.1164/rccm.201504-0781OC .
doi: 10.1164/rccm.201504-0781OC
pubmed: 26414292
Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6. https://doi.org/10.1016/S2213-2600(14)70061-X .
doi: 10.1016/S2213-2600(14)70061-X
pubmed: 24740011
Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness—a unifying pathophysiologic mechanism. Crit Care Lond Engl. 2017;21(1):25. https://doi.org/10.1186/s13054-017-1605-5 .
doi: 10.1186/s13054-017-1605-5
Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care Lond Engl. 2019;23(1):16. https://doi.org/10.1186/s13054-018-2292-6 .
doi: 10.1186/s13054-018-2292-6
Wu F, Chipman A, Pati S, Miyasawa B, Corash L, Kozar RA. Resuscitative strategies to modulate the endotheliopathy of trauma: from cell to patient. Shock Augusta Ga. 2020;53(5):575–84. https://doi.org/10.1097/SHK.0000000000001378 .
doi: 10.1097/SHK.0000000000001378
pubmed: 31090680
Johansson PI, Stensballe J, Rosenberg I, Hilsløv TL, Jørgensen L, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion (Paris). 2007;47(4):593–8. https://doi.org/10.1111/j.1537-2995.2007.01160.x .
doi: 10.1111/j.1537-2995.2007.01160.x
Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805–13. https://doi.org/10.1097/TA.0b013e3181271ba3 .
doi: 10.1097/TA.0b013e3181271ba3
pubmed: 18090009
Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447–58. https://doi.org/10.1097/SLA.0b013e318185a9ad .
doi: 10.1097/SLA.0b013e318185a9ad
pubmed: 18791365
Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma. 2009;66(1):41–8. https://doi.org/10.1097/TA.0b013e31819313bb . (discussion 48-49).
doi: 10.1097/TA.0b013e31819313bb
pubmed: 19131804
Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion (Paris). 2010;50(2):493–500. https://doi.org/10.1111/j.1537-2995.2009.02414.x .
doi: 10.1111/j.1537-2995.2009.02414.x
Sperry JL, Guyette FX, Brown JB, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;379(4):315–26. https://doi.org/10.1056/NEJMoa1802345 .
doi: 10.1056/NEJMoa1802345
pubmed: 30044935
Torres LN, Sondeen JL, Ji L, Dubick MA, Torres FI. Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg. 2013;75(5):759–66. https://doi.org/10.1097/TA.0b013e3182a92514 .
doi: 10.1097/TA.0b013e3182a92514
pubmed: 24158192
Zhang L, Zeng M, Fan J, Tarbell JM, Curry FRE, Fu BM. Sphingosine-1-phosphate maintains normal vascular permeability by preserving endothelial surface glycocalyx in intact microvessels. Microcirc N Y N 1994. 2016;23(4):301–10.
Adamson RH, Clark JF, Radeva M, Kheirolomoom A, Ferrara KW, Curry FE. Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect. Am J Physiol Heart Circ Physiol. 2014;306(7):H1011-1017. https://doi.org/10.1152/ajpheart.00829.2013 .
doi: 10.1152/ajpheart.00829.2013
pubmed: 24531813
pmcid: 3962635
Lopez E, Peng Z, Kozar RA, et al. Antithrombin III contributes to the protective effects of fresh frozen plasma following hemorrhagic shock by preventing syndecan-1 shedding and endothelial barrier disruption. Shock Augusta Ga. 2020;53(2):156–63. https://doi.org/10.1097/SHK.0000000000001432 .
doi: 10.1097/SHK.0000000000001432
pubmed: 31389906
Deng X, Cao Y, Huby MP, et al. Adiponectin in fresh frozen plasma contributes to restoration of vascular barrier function after hemorrhagic shock. Shock Augusta Ga. 2016;45(1):50–4. https://doi.org/10.1097/SHK.0000000000000458 .
doi: 10.1097/SHK.0000000000000458
pubmed: 26263440
Haywood-Watson RJ, Holcomb JB, Gonzalez EA, et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS ONE. 2011;6(8): e23530. https://doi.org/10.1371/journal.pone.0023530 .
doi: 10.1371/journal.pone.0023530
pubmed: 21886795
pmcid: 3158765
Kozar RA, Peng Z, Zhang R, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112(6):1289–95. https://doi.org/10.1213/ANE.0b013e318210385c .
doi: 10.1213/ANE.0b013e318210385c
pubmed: 21346161
pmcid: 3102787
Peng Z, Pati S, Potter D, et al. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock Augusta Ga. 2013;40(3):195–202. https://doi.org/10.1097/SHK.0b013e31829f91fc .
doi: 10.1097/SHK.0b013e31829f91fc
pubmed: 23807246
Nohé B, Kiefer RT, Ploppa A, Haeberle HA, Schroeder TH, Dieterich HJ. The effects of fresh frozen plasma on neutrophil-endothelial interactions. Anesth Analg. 2003;97(1):216–21. https://doi.org/10.1213/01.ane.0000065906.35792.dd .
doi: 10.1213/01.ane.0000065906.35792.dd
pubmed: 12818969
Diebel ME, Diebel LN, Liberati DM. Protective effects of plasma products on the endothelial-glycocalyx barrier following trauma-hemorrhagic shock: Is sphingosine-1 phosphate responsible? J Trauma Acute Care Surg. 2019;87(5):1061–9. https://doi.org/10.1097/TA.0000000000002446 .
doi: 10.1097/TA.0000000000002446
pubmed: 31453986
Jaffe EA. Cell biology of endothelial cells. Hum Pathol. 1987;18(3):234–9. https://doi.org/10.1016/s0046-8177(87)80005-9 .
doi: 10.1016/s0046-8177(87)80005-9
pubmed: 3546072
Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–67. https://doi.org/10.1146/annurev.bioeng.9.060906.151959 .
doi: 10.1146/annurev.bioeng.9.060906.151959
pubmed: 17373886
Filmus J, Capurro M, Rast J. Glypicans. Genome Biol. 2008;9(5):224. https://doi.org/10.1186/gb-2008-9-5-224 .
doi: 10.1186/gb-2008-9-5-224
pubmed: 18505598
pmcid: 2441458
Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J. 1997;327(1):1–16. https://doi.org/10.1042/bj3270001 .
doi: 10.1042/bj3270001
pubmed: 9355727
pmcid: 1218755
Saito A, Munakata H. Analysis of plasma proteins that bind to glycosaminoglycans. Biochim Biophys Acta. 2007;1770(2):241–6. https://doi.org/10.1016/j.bbagen.2006.10.015 .
doi: 10.1016/j.bbagen.2006.10.015
pubmed: 17178194
Varki A, Cummings RD, Esko JD, et al editors. Essentials of glycobiology. 4th ed. New York: Cold Spring Harbor Laboratory Press; 2022.
Reitsma S, Slaaf DW, Vink H, van Zandvoort MAMJ, Oude Egbrink MGA. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345–59. https://doi.org/10.1007/s00424-007-0212-8 .
doi: 10.1007/s00424-007-0212-8
pubmed: 17256154
pmcid: 1915585
Schött U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand J Trauma Resusc Emerg Med. 2016;24:48. https://doi.org/10.1186/s13049-016-0239-y .
doi: 10.1186/s13049-016-0239-y
pubmed: 27068016
pmcid: 4828893
Roumenina LT, Rayes J, Frimat M, Fremeaux-Bacchi V. Endothelial cells: source, barrier, and target of defensive mediators. Immunol Rev. 2016;274(1):307–29. https://doi.org/10.1111/imr.12479 .
doi: 10.1111/imr.12479
pubmed: 27782324
Daniel AE, van Buul JD. Endothelial junction regulation: a prerequisite for leukocytes crossing the vessel wall. J Innate Immun. 2013;5(4):324–35. https://doi.org/10.1159/000348828 .
doi: 10.1159/000348828
pubmed: 23571667
pmcid: 6741525
Salvador B, Arranz A, Francisco S, et al. Modulation of endothelial function by Toll like receptors. Pharmacol Res. 2016;108:46–56. https://doi.org/10.1016/j.phrs.2016.03.038 .
doi: 10.1016/j.phrs.2016.03.038
pubmed: 27073018
Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69(7):777–84. https://doi.org/10.1111/anae.12661 .
doi: 10.1111/anae.12661
pubmed: 24773303
Yen W, Cai B, Yang J, et al. Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo. PLoS ONE. 2015;10(1):e0117133. https://doi.org/10.1371/journal.pone.0117133 .
doi: 10.1371/journal.pone.0117133
pubmed: 25575016
pmcid: 4289188
Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021;117(1):60–73. https://doi.org/10.1093/cvr/cvaa070 .
doi: 10.1093/cvr/cvaa070
pubmed: 32215570
Lygizos MI, Yang Y, Altmann CJ, et al. Heparanase mediates renal dysfunction during early sepsis in mice. Physiol Rep. 2013;1(6):e00153. https://doi.org/10.1002/phy2.153 .
doi: 10.1002/phy2.153
pubmed: 24400155
pmcid: 3871468
Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8):1217–23. https://doi.org/10.1038/nm.2843 .
doi: 10.1038/nm.2843
pubmed: 22820644
Mulivor AW, Lipowsky HH. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirc N Y N 1994. 2009;16(8):657–66. https://doi.org/10.3109/10739680903133714 .
doi: 10.3109/10739680903133714
Garsen M, Benner M, Dijkman HB, et al. Heparanase is essential for the development of acute experimental glomerulonephritis. Am J Pathol. 2016;186(4):805–15. https://doi.org/10.1016/j.ajpath.2015.12.008 .
doi: 10.1016/j.ajpath.2015.12.008
pubmed: 26873445
Zeng Y, Adamson RH, Curry FRE, Tarbell JM. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol. 2014;306(3):H363-372. https://doi.org/10.1152/ajpheart.00687.2013 .
doi: 10.1152/ajpheart.00687.2013
pubmed: 24285115
Jedlicka J, Becker BF, Chappell D. Endothelial Glycocalyx. Crit Care Clin. 2020;36(2):217–32. https://doi.org/10.1016/j.ccc.2019.12.007 .
doi: 10.1016/j.ccc.2019.12.007
pubmed: 32172810
Naumann DN, Hazeldine J, Davies DJ, et al. Endotheliopathy of trauma is an on-scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study. Shock Augusta Ga. 2018;49(4):420–8. https://doi.org/10.1097/SHK.0000000000000999 .
doi: 10.1097/SHK.0000000000000999
pubmed: 28945676
Barry M, Pati S. Targeting repair of the vascular endothelium and glycocalyx after traumatic injury with plasma and platelet resuscitation. Matrix Biol Plus. 2022;14:100107. https://doi.org/10.1016/j.mbplus.2022.100107 .
doi: 10.1016/j.mbplus.2022.100107
pubmed: 35392184
pmcid: 8981767
Wei S, Gonzalez Rodriguez E, Chang R, et al. Elevated syndecan-1 after trauma and risk of sepsis: a secondary analysis of patients from the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial. J Am Coll Surg. 2018;227(6):587–95. https://doi.org/10.1016/j.jamcollsurg.2018.09.003 .
doi: 10.1016/j.jamcollsurg.2018.09.003
pubmed: 30243993
pmcid: 6252161
Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;10(1):85. https://doi.org/10.1186/s13613-020-00697-1 .
doi: 10.1186/s13613-020-00697-1
pubmed: 32572647
pmcid: 7310051
Galvani S, Sanson M, Blaho VA, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal. 2015;8(389):ra79. https://doi.org/10.1126/scisignal.aaa2581 .
doi: 10.1126/scisignal.aaa2581
pubmed: 26268607
pmcid: 4768813
Christensen PM, Liu CH, Swendeman SL, et al. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1. FASEB J Off Publ Fed Am Soc Exp Biol. 2016;30(6):2351–9. https://doi.org/10.1096/fj.201500064 .
doi: 10.1096/fj.201500064
Christoffersen C, Obinata H, Kumaraswamy SB, et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011;108(23):9613–8. https://doi.org/10.1073/pnas.1103187108 .
doi: 10.1073/pnas.1103187108
pubmed: 21606363
pmcid: 3111292
Chappell D, Jacob M, Hofmann-Kiefer K, et al. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res. 2009;83(2):388–96. https://doi.org/10.1093/cvr/cvp097 .
doi: 10.1093/cvr/cvp097
pubmed: 19307232
Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009;104(1):78–89. https://doi.org/10.1007/s00395-008-0749-5 .
doi: 10.1007/s00395-008-0749-5
pubmed: 18836678
Lamboo M, Poland DCW, Eikenboom JCJ, et al. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures. Transfus Med Oxf Engl. 2007;17(3):182–6. https://doi.org/10.1111/j.1365-3148.2007.00729.x .
doi: 10.1111/j.1365-3148.2007.00729.x
Sidhu RS, Le T, Brimhall B, Thompson H. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1–6 degrees C for five days. J Clin Apheresis. 2006;21(4):224–6. https://doi.org/10.1002/jca.20095 .
doi: 10.1002/jca.20095
pubmed: 16607628
Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion (Paris). 2001;41(4):570. https://doi.org/10.1046/j.1537-2995.2001.41040570.x .
doi: 10.1046/j.1537-2995.2001.41040570.x
Pusateri AE, Given MB, Schreiber MA, et al. Dried plasma: state of the science and recent developments. Transfusion (Paris). 2016;56(Suppl 2):S128-139. https://doi.org/10.1111/trf.13580 .
doi: 10.1111/trf.13580
Mok G, Hoang R, Khan MW, et al. Freeze-dried plasma for major trauma - Systematic review and meta-analysis. J Trauma Acute Care Surg. 2021;90(3):589–602. https://doi.org/10.1097/TA.0000000000003012 .
doi: 10.1097/TA.0000000000003012
pubmed: 33507025
Pati S, Matijevic N, Doursout MF, et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69(Suppl 1):S55-63. https://doi.org/10.1097/TA.0b013e3181e453d4 .
doi: 10.1097/TA.0b013e3181e453d4
pubmed: 20622621
pmcid: 3126659
Deb S, Sun L, Martin B, et al. Lactated ringer’s solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma. 2000;49(1):47–53. https://doi.org/10.1097/00005373-200007000-00007 . (discussion 53-55).
doi: 10.1097/00005373-200007000-00007
pubmed: 10912857
Wataha K, Menge T, Deng X, et al. Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion (Paris). 2013;53(Suppl 1):80S-90S. https://doi.org/10.1111/trf.12040 .
doi: 10.1111/trf.12040
Torres Filho IP, Torres LN, Salgado C, Dubick MA. Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids. Am J Physiol Heart Circ Physiol. 2016;310(11):H1468-1478. https://doi.org/10.1152/ajpheart.00006.2016 .
doi: 10.1152/ajpheart.00006.2016
pubmed: 27037369
Spinella PC, Perkins JG, Grathwohl KW, et al. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma. 2008;64(2 Suppl):S69-77. https://doi.org/10.1097/TA.0b013e318160ba2f .
doi: 10.1097/TA.0b013e318160ba2f
pubmed: 18376175
Brown LM, Aro SO, Cohen MJ, et al. A high fresh frozen plasma: packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regardless of admission international normalized ratio. J Trauma. 2011;71(2 Suppl 3):S358-363. https://doi.org/10.1097/TA.0b013e318227f152 .
doi: 10.1097/TA.0b013e318227f152
pubmed: 21814104
pmcid: 4374732
Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–36. https://doi.org/10.1001/2013.jamasurg.387 .
doi: 10.1001/2013.jamasurg.387
pubmed: 23560283
pmcid: 3740072
Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82. https://doi.org/10.1001/jama.2015.12 .
doi: 10.1001/jama.2015.12
pubmed: 25647203
pmcid: 4374744
Holcomb JB, Donathan DP, Cotton BA, et al. Prehospital transfusion of plasma and red blood cells in trauma patients. Prehosp Emerg Care. 2015;19(1):1–9. https://doi.org/10.3109/10903127.2014.923077 .
doi: 10.3109/10903127.2014.923077
pubmed: 24932734
Gruen DS, Brown JB, Guyette FX, et al. Prehospital plasma is associated with distinct biomarker expression following injury. JCI Insight. 2020;5(8):e135350. https://doi.org/10.1172/jci.insight.135350 .
doi: 10.1172/jci.insight.135350
pubmed: 32229722
pmcid: 7205428
Nelson A, Berkestedt I, Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol Scand. 2014;58(1):36–43. https://doi.org/10.1111/aas.12223 .
doi: 10.1111/aas.12223
pubmed: 24341693
Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock Augusta Ga. 2008;30(6):623–7. https://doi.org/10.1097/SHK.0b013e3181777da3 .
doi: 10.1097/SHK.0b013e3181777da3
pubmed: 18497712
Anand D, Ray S, Srivastava LM, Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. Clin Biochem. 2016;49(10–11):768–76. https://doi.org/10.1016/j.clinbiochem.2016.02.014 .
doi: 10.1016/j.clinbiochem.2016.02.014
pubmed: 26953518
Ikeda M, Matsumoto H, Ogura H, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J Crit Care. 2018;43:48–53. https://doi.org/10.1016/j.jcrc.2017.07.049 .
doi: 10.1016/j.jcrc.2017.07.049
pubmed: 28843664
Chen S, He Y, Hu Z, et al. Heparanase mediates intestinal inflammation and injury in a mouse model of sepsis. J Histochem Cytochem. 2017;65(4):241–9. https://doi.org/10.1369/0022155417692536 .
doi: 10.1369/0022155417692536
pubmed: 28170292
pmcid: 5407566
Lever R, Rose MJ, McKenzie EA, Page CP. Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. Am J Physiol Cell Physiol. 2014;306(12):C1184-1190. https://doi.org/10.1152/ajpcell.00269.2013 .
doi: 10.1152/ajpcell.00269.2013
pubmed: 24740543
LaRivière WB, Schmidt EP. The pulmonary endothelial glycocalyx in ARDS: a critical role for heparan sulfate. Curr Top Membr. 2018;82:33–52. https://doi.org/10.1016/bs.ctm.2018.08.005 .
doi: 10.1016/bs.ctm.2018.08.005
pubmed: 30360782
Chang R, Holcomb JB, Johansson PI, Pati S, Schreiber MA, Wade CE. Plasma resuscitation improved survival in a cecal ligation and puncture rat model of sepsis. Shock Augusta Ga. 2018;49(1):53–61. https://doi.org/10.1097/SHK.0000000000000918 .
doi: 10.1097/SHK.0000000000000918
pubmed: 28591008
Scheck M, Velten M, Klaschik S, et al. Differential modulation of endothelial cell function by fresh frozen plasma. Life Sci. 2020;254: 117780. https://doi.org/10.1016/j.lfs.2020.117780 .
doi: 10.1016/j.lfs.2020.117780
pubmed: 32407844
Barry M, Wu F, Pati S, Chipman A, Geng H, Kozar R. Lyophilized plasma resuscitation downregulates inflammatory gene expression in a mouse model of sepsis. J Trauma Acute Care Surg. 2022;93(2S Suppl 1):S119–27. https://doi.org/10.1097/TA.0000000000003658 .
doi: 10.1097/TA.0000000000003658
pubmed: 35881828
Straat M, Müller MCA, Meijers JCM, et al. Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial. Crit Care Lond Engl. 2015;19(1):163. https://doi.org/10.1186/s13054-015-0828-6 .
doi: 10.1186/s13054-015-0828-6
El-Nawawy AA, Elshinawy MI, Khater DM, et al. Outcome of early hemostatic intervention in children with sepsis and nonovert disseminated intravascular coagulation admitted to PICU: a randomized controlled trial. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2021;22(3):e168–77. https://doi.org/10.1097/PCC.0000000000002578 .
doi: 10.1097/PCC.0000000000002578
Dietrich M, Hölle T, Lalev LD, et al. Plasma transfusion in septic shock—a secondary analysis of a retrospective single-center cohort. J Clin Med. 2022;11(15):4367. https://doi.org/10.3390/jcm11154367 .
doi: 10.3390/jcm11154367
pubmed: 35955987
pmcid: 9369152
Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol. 2009;147(4):431–43. https://doi.org/10.1111/j.1365-2141.2009.07840.x .
doi: 10.1111/j.1365-2141.2009.07840.x
pubmed: 19663827
pmcid: 4532338
Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion (Paris). 2012;52(51):65S-79S. https://doi.org/10.1111/j.1537-2995.2012.03663.x .
doi: 10.1111/j.1537-2995.2012.03663.x
Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion (Paris). 2009;49(3):440–52. https://doi.org/10.1111/j.1537-2995.2008.01948.x .
doi: 10.1111/j.1537-2995.2008.01948.x
Eder AF, Herron RM, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006–2008). Transfusion (Paris). 2010;50(8):1732–42. https://doi.org/10.1111/j.1537-2995.2010.02652.x .
doi: 10.1111/j.1537-2995.2010.02652.x
Lucas G, Win N, Calvert A, et al. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. Vox Sang. 2012;103(1):10–7. https://doi.org/10.1111/j.1423-0410.2011.01570.x .
doi: 10.1111/j.1423-0410.2011.01570.x
pubmed: 22150747
Klein HG, Dodd RY, Dzik WH, et al. Current status of solvent/detergent-treated frozen plasma. Transfusion (Paris). 1998;38(1):102–7. https://doi.org/10.1046/j.1537-2995.1998.38198141508.x .
doi: 10.1046/j.1537-2995.1998.38198141508.x
Erickson A, Waldhaus K, David T, et al. Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6o C. Transfusion (Paris). 2017;57(4):997–1006. https://doi.org/10.1111/trf.13973 .
doi: 10.1111/trf.13973
Zander AL, Olson EJ, Van Gent JM, et al. Does resuscitation with plasma increase the risk of venous thromboembolism? J Trauma Acute Care Surg. 2015;78(1):39–44. https://doi.org/10.1097/TA.0000000000000480 .
doi: 10.1097/TA.0000000000000480
pubmed: 25539201
Iannizzi C, Chai KL, Piechotta V, et al. Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2023;2(2):CD013600. https://doi.org/10.1002/14651858.CD013600.pub5 .
doi: 10.1002/14651858.CD013600.pub5
pubmed: 36734509
Pati S, Peng Z, Wataha K, Miyazawa B, Potter DR, Kozar RA. Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock. PLOS ONE. 2018;13(2):e0192363.
doi: 10.1371/journal.pone.0192363
pubmed: 29394283
pmcid: 5796727
Diebel LN, Martin JV, Liberati DM. Microfluidics: A high-throughput system for the assessment of the endotheliopathy of trauma and the effect of timing of plasma administration on ameliorating shock-associated endothelial dysfunction. J Trauma Acute Care Surg. 2018;84(4):575–82. https://doi.org/10.1097/TA.0000000000001791 .
doi: 10.1097/TA.0000000000001791
pubmed: 29287059
Nelson A, Statkevicius S, Schött U, Johansson PI, Bentzer P. Effects of fresh frozen plasma, Ringer’s acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in rats. Intensive Care Med Exp. 2016;4(1):6. https://doi.org/10.1186/s40635-016-0080-7 .
doi: 10.1186/s40635-016-0080-7
pubmed: 26940500
pmcid: 4777969
Potter DR, Baimukanova G, Keating SM, et al. Fresh frozen plasma and spray-dried plasma mitigate pulmonary vascular permeability and inflammation in hemorrhagic shock. J Trauma Acute Care Surg. 2015;78(6 Suppl 1):S7–17. https://doi.org/10.1097/TA.0000000000000630 .
doi: 10.1097/TA.0000000000000630
pubmed: 26002267
Moore HB, Moore EE, Chapman MP, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet Lond Engl. 2018;392(10144):283–91. https://doi.org/10.1016/S0140-6736(18)31553-8 .
doi: 10.1016/S0140-6736(18)31553-8